NEW YORK (Reuters) - Wyeth said on Tuesday it had launched a U.S. generic form of its blockbuster Protonix heartburn drug, even as it continues legal action to stop other companies from selling their ...

LOS ANGELES, July 31 (Reuters) - Wyeth and its partner Nycomed said on Tuesday that Teva Pharmaceuticals and Sun Pharmaceuticals have committed to not launching generic versions of heartburn drug ...

NEW YORK — Two generic drugmakers will pay $2.15 billion to Pfizer and Takeda Pharmaceutical to settle a patent fight over the heartburn treatment Protonix. Teva Pharmaceutical Industries Ltd., one of ...

The prospect of early generic competition to Protonix, Wyeth's billion-dollar heartburn medicine, caused some industry analysts to make downward revisions Wednesday in their earnings forecasts for the ...

SAN FRANCISCO (MarketWatch) -- Teva Pharmaceutical Industries Ltd. said Thursday the Food and Drug Administration granted it approval to market a generic version of Wyeth's Protonix tablets, 20 mg and ...

Generic drug maker Teva Pharmaceutical said today the company has agreed to extend its deal with Madison-based Wyeth and its partner Altana Pharma AG not to market a generic version of heartburn drug ...

Pantoprazole (as sodium) 40mg; per pkt; e-c del-rel granules. Swallow whole. Do not crush or chew granules. Susp: Take 30mins before a meal. Mix contents of packet in 5mL of apple juice or applesauce ...

NEW YORK (AP) — Two generic drugmakers will pay $2.15 billion to Pfizer and Takeda Pharmaceutical to settle a patent fight over the heartburn treatment Protonix. Teva Pharmaceutical Industries Ltd., ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) reported today that its Wyeth subsidiary has reached an agreement in principle to resolve claims alleging that Wyeth’s practices relating to the ...